TLR7 and metabolic dysfunction-associated steatohepatitis: The role of TLR7 in NASH/NAFLD, liver fibrosis, or liver cirrhosis has been widely overlooked in the clinical setting; however, recent studies suggest that ALD-mediated inflammation and fibrosis is linked to hepatic TLR7 overexpression [130,131].